Figure 6.

Waterfall plot of RAS signature score in patients who experienced disease control (blue) or progressive disease (red) after Cetuximab therapy. The Y-axis shows RAS signature score relative to the mean of all tumors in this dataset. Fisher's exact test p-value for the difference between the disease control and progressive disease groups is shown. Data is derived from [5], and includes all patients with known response.

Loboda et al. BMC Medical Genomics 2010 3:26   doi:10.1186/1755-8794-3-26
Download authors' original image